GEnetic Testing in Elective Single Embryo Transfer (GETSET): A Randomized Clinical Trial

Recruiting now · Not applicable

Conditions studied: Infertility, Female

In brief

The GETSET trial is a prospective randomized trial designed to evaluate the clinical outcomes of incorporating preimplantation genetic testing for aneuploidies (PGT-A) in elective single embryo transfer in women between 35 and 40 years of age.

Key facts

Study ID

NCT06141135

Run by

Genomic Prediction Inc.

People needed

240

Starts

2023-11-15

Expected to finish

2026-11-15

Last updated by the study team

2025-08-26

Who can join

Age: 35 and older, up to 40. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Women undergoing IVF of between 35 and 40 years of age at IVF cycle start
• Utilization of Intracytoplasmic Sperm Injection ICSI (recommended) or ---Traditional IVF
• Utilization of ejaculated or testicular sperm
• Utilization of autologous or donor sperm
• All Controlled Ovarian Hyperstimulation (COH) protocols

You may not qualify if…

• Utilization of donor oocytes
• Utilization of gestational carrier
• Recurrent Pregnancy Loss (RPL) defined as ≥ 3 consecutive miscarriages
• Recurrent Implantation Failure (RIF) defined as ≥ 3 more failed embryo transfers
• Preimplantation genetic testing for monogenic/single gene disorders (PGT-M)
• Translocation carriers

Where it is running

• Boston IVF — Waltham, Massachusetts, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.